Results 281 to 290 of about 752,420 (346)

New Horizons for Multiple Sclerosis Therapy: 2025 and Beyond

Annals of Neurology, EarlyView.
The advances achieved against multiple sclerosis (MS) represent one of the great success stories of modern molecular medicine. The development of therapies with increasing selectivity and safety, guided by gains in understanding the fundamental immunology, neurobiology, genetics, and triggers of this disease, have broadened the traditional focus on ...
Joseph J. Sabatino Jr., Bruce A. C. Cree, Stephen L. Hauser   +2 more
wiley   +1 more source

Prevalence and incidence of multiple sclerosis in Bulgaria. [PDF]

Front Neurol
Nikolova A, Milanov I, Kmetska K.
europepmc   +1 more source

Visual Features in Stereo‐Electroencephalography to Predict Surgical Outcome: A Multicenter Study

Annals of Neurology, EarlyView.
Objective Epilepsy surgery needs predictive features that are easily implemented in clinical practice. Previous studies are limited by small sample sizes, lack of external validation, and complex computational approaches. We aimed to identify and validate visually stereo‐electroencephalography (SEEG) features with the highest predictive value for ...
Chifaou Abdallah, John Thomas, Olivier Aron, Tamir Avigdor, Kassem Jaber, Irena Doležalová, Daniel Mansilla, Päivi Nevalainen, Prachi Parikh, Jaysingh Singh, Sandor Beniczky, Philippe Kahane, Lorella Minotti, Stephan Chabardes, Sophie Colnat‐Coulbois, Louis Maillard, Jeff Hall, Francois Dubeau, Jean Gotman, Christophe Grova, Birgit Frauscher   +20 more
wiley   +1 more source

Update in multiple sclerosis. [PDF]

eNeurologicalSci
Yamout B.
europepmc   +1 more source

Toward Natural Limb Function: A New Era in Prosthetic Innovation

Annals of Neurology, EarlyView.
The past decade has witnessed groundbreaking clinical implementation of neuroprosthetic limbs driven by signals from peripheral targets (eg, nerves and muscle) and the brain to restore limb function for individuals with limb loss or impairment. In this review, we highlight recent key clinical trials in peripheral neuroprosthetic interfaces directly ...
Yucheng Tian, Dylan M. Wallace, Paul S. Cederna, Cynthia A. Chestek, Stephen W. P. Kemp   +4 more
wiley   +1 more source

Adherence to therapeutic recommendation in relapsing-remitting multiple sclerosis patients. [PDF]

Front Immunol
Chojdak-Łukasiewicz J, Kołtuniuk A, Sawicka E, Pokryszko-Dragan A.   +3 more
europepmc   +1 more source

High‐Dose Pulse Glucocorticoid Treatment Prevents White Matter Spinal Cord Pseudoatrophy in Newly Diagnosed Multiple Sclerosis

Annals of Neurology, EarlyView.
Objective Spinal cord (SC) atrophy correlates with and predicts the underlying progressive biology in active and non‐active multiple sclerosis (MS), thereby providing a biomarker for clinical trials and patient management. Initiation of disease‐modifying therapy (DMT) may be followed by early pronounced central nervous system (CNS) volume loss due to ...
Simone Sacco, Nico Papinutto, Vinicius A. Schoeps, Shuiting Cheng, William A. Stern, Haojun Zhao, Antje Bischof, Eduardo Caverzasi, Manula Dombagahawatta, Jeremy Juwono, Amit Akula, Christian Cordano, Alexandra Beaudry‐Richard, Refujia Gomez, Meagan Harms, Adam Santaniello, Riley M. Bove, Jeffrey M. Gelfand, Douglas S. Goodin, Ari J. Green, Jorge R. Oksenberg, Emmanuelle Waubant, Michael R. Wilson, Scott S. Zamvil, Bruce A. C. Cree, Stephen L. Hauser, Roland G. Henry   +26 more
wiley   +1 more source

Semi-Supervised Learning for Predicting Multiple Sclerosis. [PDF]

J Pers Med
Kotsiantis S, Melagraki G, Verykios V, Sakagianni A, Matsoukas J.   +4 more
europepmc   +1 more source